BR0005122A - Método para a preparação de inibidor de permutador de sódio-hidrogênio do tipo 1 - Google Patents
Método para a preparação de inibidor de permutador de sódio-hidrogênio do tipo 1Info
- Publication number
- BR0005122A BR0005122A BR0005122-5A BR0005122A BR0005122A BR 0005122 A BR0005122 A BR 0005122A BR 0005122 A BR0005122 A BR 0005122A BR 0005122 A BR0005122 A BR 0005122A
- Authority
- BR
- Brazil
- Prior art keywords
- sodium
- preparation
- type
- hydrogen exchanger
- exchanger inhibitor
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title abstract 4
- 102000052126 Sodium-Hydrogen Exchangers Human genes 0.000 title abstract 2
- 108091006672 Sodium–hydrogen antiporter Proteins 0.000 title abstract 2
- 102100030980 Sodium/hydrogen exchanger 1 Human genes 0.000 abstract 2
- 108010093115 growth factor-activatable Na-H exchanger NHE-1 Proteins 0.000 abstract 2
- 208000028867 ischemia Diseases 0.000 abstract 1
- 230000000451 tissue damage Effects 0.000 abstract 1
- 231100000827 tissue damage Toxicity 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
- C07C279/10—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by doubly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16237799P | 1999-10-29 | 1999-10-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0005122A true BR0005122A (pt) | 2001-06-19 |
Family
ID=22585372
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0005122-5A BR0005122A (pt) | 1999-10-29 | 2000-10-30 | Método para a preparação de inibidor de permutador de sódio-hidrogênio do tipo 1 |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6441176B1 (enExample) |
| EP (1) | EP1101763A3 (enExample) |
| JP (1) | JP3342475B2 (enExample) |
| KR (2) | KR100449595B1 (enExample) |
| CN (1) | CN1146557C (enExample) |
| AR (1) | AR029188A1 (enExample) |
| AU (1) | AU779106B2 (enExample) |
| BR (1) | BR0005122A (enExample) |
| CA (1) | CA2324640A1 (enExample) |
| CZ (1) | CZ20004018A3 (enExample) |
| HU (1) | HUP0004187A2 (enExample) |
| ID (1) | ID27904A (enExample) |
| IL (1) | IL139198A0 (enExample) |
| PL (1) | PL343542A1 (enExample) |
| RU (1) | RU2190605C2 (enExample) |
| TR (1) | TR200003143A2 (enExample) |
| TW (1) | TWI221152B (enExample) |
| YU (1) | YU62900A (enExample) |
| ZA (1) | ZA200006007B (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6852733B2 (en) | 2000-04-28 | 2005-02-08 | Pfizer Inc. | Sodium-hydrogen exchanger type 1 inhibitor |
| CA2436539A1 (en) * | 2001-01-31 | 2002-08-08 | Pfizer Products Inc. | Ethanolates of sodium-hydrogen exchanger type-1 inhibitor |
| MXPA04004685A (es) * | 2001-12-19 | 2004-08-12 | Pfizer Prod Inc | Procedimientos para preparar inhibidores de tipo-1 de intercambiador sodio-hidrogeno. |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4028381A (en) * | 1975-05-05 | 1977-06-07 | Ciba-Geigy Corporation | Pyrazolobenzazepines |
| DE4226649A1 (de) * | 1992-08-12 | 1994-02-17 | Bayer Ag | Neue isobutylsubstituierte Methansulfonyl-chinolylmethoxyphenyl-cycloalkylessigsäureaminole |
| RU2009129C1 (ru) * | 1991-12-16 | 1994-03-15 | Центр по химии лекарственных средств | Арилгидразоны 5,6,7,8-тетрагидрохинолиндионы-2,5, обладающие кардиотонической активностью |
| US6184380B1 (en) * | 1999-01-25 | 2001-02-06 | Pfizer Inc. | Process for preparing naphthyridones and intermediates |
| JP2002504546A (ja) | 1998-02-27 | 2002-02-12 | ファイザー・プロダクツ・インク | 虚血の治療のためのｎ−［（置換５員ジもしくはトリアザ二不飽和環）カルボニル］グアニジン誘導体 |
| UA72002C2 (en) | 1999-10-29 | 2005-01-17 | Pfizer Prod Inc | Inhibitors crystals of sodium-hydrogen exchange of 1 type, a method for the preparation thereof (variants), a pharmaceuticalcomposition based thereon and a method for the reduction of tissue damage |
-
2000
- 2000-08-10 US US09/636,406 patent/US6441176B1/en not_active Expired - Fee Related
- 2000-09-27 AU AU61333/00A patent/AU779106B2/en not_active Ceased
- 2000-10-12 EP EP00308971A patent/EP1101763A3/en not_active Withdrawn
- 2000-10-16 YU YU62900A patent/YU62900A/sh unknown
- 2000-10-23 TW TW089122257A patent/TWI221152B/zh not_active IP Right Cessation
- 2000-10-23 IL IL13919800A patent/IL139198A0/xx unknown
- 2000-10-24 CN CNB001316613A patent/CN1146557C/zh not_active Expired - Fee Related
- 2000-10-26 ZA ZA200006007A patent/ZA200006007B/xx unknown
- 2000-10-26 TR TR2000/03143A patent/TR200003143A2/xx unknown
- 2000-10-26 JP JP2000326431A patent/JP3342475B2/ja not_active Expired - Fee Related
- 2000-10-27 PL PL00343542A patent/PL343542A1/xx not_active Application Discontinuation
- 2000-10-27 HU HU0004187A patent/HUP0004187A2/hu unknown
- 2000-10-27 CZ CZ20004018A patent/CZ20004018A3/cs unknown
- 2000-10-27 CA CA002324640A patent/CA2324640A1/en not_active Abandoned
- 2000-10-27 RU RU2000126970/04A patent/RU2190605C2/ru not_active IP Right Cessation
- 2000-10-27 ID IDP20000929A patent/ID27904A/id unknown
- 2000-10-27 AR ARP000105697A patent/AR029188A1/es unknown
- 2000-10-28 KR KR10-2000-0063690A patent/KR100449595B1/ko not_active Expired - Fee Related
- 2000-10-30 BR BR0005122-5A patent/BR0005122A/pt not_active IP Right Cessation
-
2003
- 2003-06-30 KR KR10-2003-0043245A patent/KR100443851B1/ko not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| YU62900A (sh) | 2003-08-29 |
| KR100449595B1 (ko) | 2004-09-21 |
| CA2324640A1 (en) | 2001-04-29 |
| AR029188A1 (es) | 2003-06-18 |
| TR200003143A2 (tr) | 2001-05-21 |
| JP3342475B2 (ja) | 2002-11-11 |
| CN1146557C (zh) | 2004-04-21 |
| US6441176B1 (en) | 2002-08-27 |
| PL343542A1 (en) | 2001-05-07 |
| KR20010060211A (ko) | 2001-07-06 |
| IL139198A0 (en) | 2001-11-25 |
| RU2190605C2 (ru) | 2002-10-10 |
| CZ20004018A3 (cs) | 2002-04-17 |
| ID27904A (id) | 2001-05-03 |
| TWI221152B (en) | 2004-09-21 |
| JP2001158784A (ja) | 2001-06-12 |
| HK1036057A1 (en) | 2003-07-10 |
| CN1295070A (zh) | 2001-05-16 |
| ZA200006007B (en) | 2002-04-26 |
| EP1101763A3 (en) | 2002-04-24 |
| EP1101763A2 (en) | 2001-05-23 |
| HUP0004187A2 (hu) | 2002-11-28 |
| AU6133300A (en) | 2001-05-03 |
| AU779106B2 (en) | 2005-01-06 |
| KR20030061767A (ko) | 2003-07-22 |
| KR100443851B1 (ko) | 2004-08-11 |
| HU0004187D0 (enExample) | 2001-01-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0110101A (pt) | N-acil-sulfonamidas promotoras de apoptose | |
| DK1244647T3 (da) | Quinzolinderivater som VIGF-inhibitorer | |
| ATE524441T1 (de) | Vla-4-inhibitoren | |
| PT1162969E (pt) | Utilizacao de inibidores da dipeptidilpeptidase iv para a melhoria da fertilidade | |
| BR0112786A (pt) | Inibidores de inflamação não-esteroidais | |
| DK2253620T3 (da) | Substituerede 3-cyanoquinoliner som protein-tyrosinkinase-inhibitorer | |
| NO20021407D0 (no) | Bifenylderivater anvendt som NHE-3-inhibitorer | |
| NO996491D0 (no) | 4-brom- eller 4-iod-fenylaminobenzhydroksamsyre-derivater og deres anvendelse som MEK-inhibitorer | |
| NO20021239L (no) | Pteridinoner som kinase-inhibitorer | |
| DZ3192A1 (fr) | Dérivés de diaryl ether utilises comme inhibiteursdu recaptage de monoamines. | |
| NO20026010L (no) | Substituerte quinazolinderivater og deres anvendelse som inhibitorer | |
| NO20016319L (no) | VLA-4 inhibitor-forbindelser | |
| NO20003018D0 (no) | Triazinangiogenese-inhibitorer | |
| NO20010203D0 (no) | Diacylhydrazinderivater som integrininhibitorer | |
| NO20024997D0 (no) | 2-guanidino-4-arylkinazoliner som NHE-3-inhibitorer | |
| DK1556371T3 (da) | Benzimidazol-derivater og deres anvendelse som prodrugs for protonpumpe-inhibitorer | |
| BR0212925A (pt) | Derivados de idol como inibidores de cox ii | |
| PT1250340E (pt) | Metodos e compostos para inibicao de mrp1 | |
| PT1171440E (pt) | 3-ciano-¬1,7|,¬1,5|, e ¬1,8|-naftiridinas substituidas inibidoras de tirosina quinases | |
| NO991994L (no) | Substituerte 4-bifenyl-4-hydroksysm°rsyrederivater som matriksmetalloproteaseinhibitorer | |
| BR0115616A (pt) | Preparação de inibidores de permutadores sódio-hidrogênio do tipo 1 | |
| NO20023001D0 (no) | Substituerte piperazinderivater som MTP inhibitorer | |
| BR0112028A (pt) | Inibidores de farnesil transferase | |
| NO20030813D0 (no) | Bifenylderivater og deres anvendelse som integrininhibitorer | |
| YU79602A (en) | Sodium-hydrogen exchanger type 1 inhibitor (nhe-1) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A, 7A E 8A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1962 DE 12/08/2008. |